Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral spironolactone plus 3% topical minoxidil in premenopausal women with female pattern hair loss
TCTR20220613005Phase 2Completed
- Sponsor
- Srinakharinwirot University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone, minoxidil in Female Pattern Hair Loss (FPHL), sponsored by Srinakharinwirot University. Started Sep 2022; status: completed.
02
Drugs
spironolactoneminoxidil
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on TCTR20220613005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220613005.